MSPs debated the importance of life sciences to the Scottish economy on Wednesday to mark the second anniversary of the industry-led Life Sciences Strategy.
North East Scotland Conservative MSP Bill Bowman praised efforts to strengthen partnerships between industry, academia and the NHS in Dundee.
He underlined the pioneering work to develop anti-cancer drugs carried out by Dundee University researchers in the 1990s, and the “pioneering” automated drug-design methodologies developed at the university.
This led to the spin out of exscientia Ltd, a leading AI British drugs design company, in 2012.
Exscientia is at the forefront of Artificial Intelligence-driven drug discovery and design. As at 30th June 2016, Frontier IP Group Plc (LON:FIPP) have a 5% holding in Exscientia. Frontier IP Group, through its subsidiaries, engages in assisting universities, research institutions, and companies in the commercialization and exploitation of their intellectual property (IP) in the United Kingdom.